# Comparison of Agent™ and SeQuent® Please Paclitaxel Coated Balloon Catheters in Coronary In-stent Restenosis (AGENT-ISR)

Study · id `cardio:ct-nct02151812` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02151812](<https://clinicaltrials.gov/study/NCT02151812>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02151812

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 123 participants.

## Technical summary

Registry record NCT02151812. Randomized; single masking; primary purpose treatment. Start 2014-08-13 (actual); primary completion 2017-04-27 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 123 participants (enrolled count; ClinicalTrials.gov record NCT02151812, source copy `cardio:ctgov-nct02151812-2019-12-23`, retrieved 2026-10-26)
- Started: 2014-08-13 (actual) (ClinicalTrials.gov record NCT02151812, source copy `cardio:ctgov-nct02151812-2019-12-23`, retrieved 2026-10-26)
- Primary completion: 2017-04-27 (actual) (ClinicalTrials.gov record NCT02151812, source copy `cardio:ctgov-nct02151812-2019-12-23`, retrieved 2026-10-26)
- Completion: 2019-10-28 (actual) (ClinicalTrials.gov record NCT02151812, source copy `cardio:ctgov-nct02151812-2019-12-23`, retrieved 2026-10-26)
- Countries: France; Germany (ClinicalTrials.gov record NCT02151812, source copy `cardio:ctgov-nct02151812-2019-12-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02151812-2019-12-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Agent™ and SeQuent® Please Paclitaxel Coated Balloon Catheters in Coronary In-stent Restenosis (AGENT-ISR)
- Acronym: AGENT-ISR
- Condition: Coronary Artery Disease
- Condition: Coronary Restenosis
- Condition: Coronary Atherosclerosis
- Condition: Coronary Arteriosclerosis
- Intervention (Device): Agent Paclitaxel-coated balloon
- Intervention (Device): SeQuent® Please Paclitaxel-coated Balloon
- Lead sponsor: Hemoteq AG
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: A multicentre, randomised controlled clinical study of drug-coated balloons for the treatment of coronary in-stent restenosis (`cardio:pubmed-31746743`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c9d38bd095013dba5124cf849340995d2f8d4a1a51ffd130c3f11cda20b88c40
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
